A Study to Evaluate the Effect of the Potent CYP3A4 Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-906 in Healthy Participants
Clinical trial NCT03161405 · COMPLETED
Trial details
- NCT number
- NCT03161405
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-05
- Primary completion
- 2017-07-02
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.